Ventyx Biosciences Inc (VTYX) surge 0.07% in a week: will this be a lucky break through?

Sana Meer

Ventyx Biosciences Inc (NASDAQ: VTYX) open the trading on Wednesday, with a bit cautious approach as it glided -0.07% to $13.87, before settling in for the price of $13.88 at the close. Taking a more long-term approach, VTYX posted a 52-week range of $0.78-$25.00.

The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -87.13%. Meanwhile, its Annual Earning per share during the time was -87.13%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 26.57%. This publicly-traded company’s shares outstanding now amounts to $71.34 million, simultaneously with a float of $64.33 million. The organization now has a market capitalization sitting at $995.17 million.

Ventyx Biosciences Inc (VTYX) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Ventyx Biosciences Inc’s current insider ownership accounts for 10.34%, in contrast to 61.56% institutional ownership. According to the most recent insider trade that took place on Dec 18 ’25, this organization’s CEO AND PRESIDENT sold 47,345 shares at the rate of 7.72, making the entire transaction reach 365,461 in total value, affecting insider ownership by 2,372,863. Preceding that transaction, on Dec 18 ’25, Company’s CHIEF SCIENTIFIC OFFICER sold 12,675 for 7.72, making the whole transaction’s value amount to 97,840. This particular insider is now the holder of 489,481 in total.

Ventyx Biosciences Inc (VTYX) Earnings and Revenue Records

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.

Ventyx Biosciences Inc’s EPS increase for this current 12-month fiscal period is 26.57% and is forecasted to reach -1.71 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 6.90% through the next 5 years, which can be compared against the -87.13% growth it accomplished over the previous five years trading on the market.

Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators

Let’s observe the current performance indicators for Ventyx Biosciences Inc (VTYX). It’s Quick Ratio in the last reported quarter now stands at 17.86.

In the same vein, VTYX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.50, a figure that is expected to reach -0.37 in the next quarter, and analysts are predicting that it will be -1.71 at the market close of one year from today.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.